CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

lanreotide (Autogel formulation), duration of treatment 24-56 weeks, depending on dose interval - Phase 3 | IPSEY Pipeline | CatalystAlert